98 related articles for article (PubMed ID: 9459332)
1. Relationship between thyroid hormones and plasma D-dimer levels.
Chadarevian R; Bruckert E; Ankri A; Beucler I; Giral P; Turpin G
Thromb Haemost; 1998 Jan; 79(1):99-103. PubMed ID: 9459332
[TBL] [Abstract][Full Text] [Related]
2. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
3. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
4. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.
Peverill RE; Teede HJ; Malan E; Kotsopoulos D; Smolich JJ; McGrath BP
Clin Sci (Lond); 2007 Nov; 113(9):383-91. PubMed ID: 17608627
[TBL] [Abstract][Full Text] [Related]
5. Dyslipidemias and fibrinolysis.
Puccetti L; Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Auteri A
Ital Heart J; 2002 Oct; 3(10):579-86. PubMed ID: 12478815
[TBL] [Abstract][Full Text] [Related]
6. Independent relation of vital exhaustion and inflammation to fibrinolysis in apparently healthy subjects.
von Känel R; Frey K; Fischer J
Scand Cardiovasc J; 2004 Mar; 38(1):28-32. PubMed ID: 15204244
[TBL] [Abstract][Full Text] [Related]
7. Blood coagulation and fibrinolytic activity in hypothyroidism.
Erem C; Kavgaci H; Ersöz HO; Hacihasanoglu A; Ukinç K; Karti SS; Deger O; Telatari M
Int J Clin Pract; 2003 Mar; 57(2):78-81. PubMed ID: 12661786
[TBL] [Abstract][Full Text] [Related]
8. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
[TBL] [Abstract][Full Text] [Related]
10. High intakes of trans monounsaturated fatty acids taken for 2 weeks do not influence procoagulant and fibrinolytic risk markers for CHD in young healthy men.
Sanders TA; Oakley FR; Crook D; Cooper JA; Miller GJ
Br J Nutr; 2003 Jun; 89(6):767-76. PubMed ID: 12828793
[TBL] [Abstract][Full Text] [Related]
11. Negative correlation between D-dimer and plasminogen activator inhibitor-1 levels is absent in obese women.
Ceo PT; Petruceli E; Bosco AA; Andrade-Fernandes CM; Russi CV; Carvalho Md; Sandrim VC
Blood Coagul Fibrinolysis; 2012 Jul; 23(5):402-5. PubMed ID: 22527291
[TBL] [Abstract][Full Text] [Related]
12. Haemostatic and lipid determinants of prothrombin fragment F1.2 and D-dimer in plasma.
MacCallum PK; Cooper JA; Martin J; Howarth DJ; Meade TW; Miller GJ
Thromb Haemost; 2000 Mar; 83(3):421-6. PubMed ID: 10744148
[TBL] [Abstract][Full Text] [Related]
13. Altered endothelial function following the Fontan procedure.
Binotto MA; Maeda NY; Lopes AA
Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
[TBL] [Abstract][Full Text] [Related]
14. [Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease].
Espinosa RA; Rodríguez-Roa E; Nagy E; Mijares ME; Rodríguez-Larralde A; Gil A; Lundberg U; Carvajal Z; Castillo L; Arocha-Piñango CL
Invest Clin; 2006 Mar; 47(1):35-48. PubMed ID: 16562643
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
[TBL] [Abstract][Full Text] [Related]
16. Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
Zitoun D; Bara L; Basdevant A; Samama MM
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):77-81. PubMed ID: 8548430
[TBL] [Abstract][Full Text] [Related]
17. Haemostatic risk factors for cardiovascular diseases.
Koenig W
Eur Heart J; 1998 Apr; 19 Suppl C():C39-43. PubMed ID: 9597424
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal study of the relationships between haemostatic, lipid, and oestradiol changes during normal human pregnancy.
Sattar N; Greer IA; Rumley A; Stewart G; Shepherd J; Packard CJ; Lowe GD
Thromb Haemost; 1999 Jan; 81(1):71-5. PubMed ID: 9974378
[TBL] [Abstract][Full Text] [Related]
19. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
[TBL] [Abstract][Full Text] [Related]
20. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
